| Authors: |
Hall K; Department of Pharmacy, Emory Winship Cancer Institute, Atlanta, GA., Lazaryan A; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL., van der Laan M; School of Public Health, Division of Biostatistics, University of California, Berkeley, Berkeley, CA., Lee C; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA., Logan AC; Department of Hematology, BMT, and Cellular Therapy, University of California, San Francisco, Medical Center, San Francisco, CA., Gruber S; Putnam Data Sciences, LLC, Cambridge, MA., Kabadi S; Sanofi, Bridgewater, NJ., Khan I; Sanofi, Bridgewater, NJ., Nicholls C; Sanofi, Reading, United Kingdom., Rota L; Sanofi, Bridgewater, NJ., Nikai E; Sanofi, Paris, France., Ponomareva E; Axtria, Berkley Heights, NJ., Koumas A; Axtria, Berkley Heights, NJ., Waller EK; Department of Hematology and Medical Oncology, Emory Winship Cancer Institute, Emory University, Atlanta, GA. |
